Personal profile
External positions
University of Southern Denmark
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 1 Finished
-
HISTORI: Effect of Semaglutide versus placebo on prediabetes, psychotic symptoms, and quality of life – part of HISTORI: A randomized clinical trial in people with schizophrenia.
Uhrenholt, N. G. (Project manager/Co-project manager), Ganeshalingam, A. (Project manager/Co-project manager), Arnfred, S. M. (Project manager/Co-project manager), Frystyk , J. (Lead), Gæde, P. H. (Project manager/Co-project manager) & Bilenberg, N. (Project manager/Co-project manager)
1/08/20 → 31/12/24
Project: Research
-
Cardiac autonomic neuropathy in patients with SGA-treated schizophrenia: a randomized controlled trial of 30 weeks' treatment with semaglutide
Ganeshalingam, A. A., Uhrenholt, N. G., Arnfred, S., Gæde, P., Pedersen, A. K., Bilenberg, N. & Frystyk, J., 20 Jan 2026, In: Cardiovascular diabetology. Endocrinology reports. 12, 1, p. 2Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Improved quality of life with semaglutide in schizophrenia: Secondary analyses from a randomized controlled trial
Uhrenholt, N., Ganeshalingam, A., Arnfred, S., Gæde, P., Pedersen, A. K., Larsen, P. V., Frystyk, J. & Bilenberg, N., May 2026, In: Schizophrenia Research. 291, p. 20-26 7 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Semaglutide Effects on Insulin Sensitivity and β-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial With Semaglutide 1.0 mg Weekly
Ganeshalingam, A. A., Uhrenholt, N., Arnfred, S., Gæde, P., Pedersen, A. K., Bilenberg, N. & Frystyk, J., 1 May 2026, In: Diabetes Care. 49, 5, p. 800-807 8 p.Research output: Contribution to journal › Article › Research › peer-review
-
The adverse effects associated with tirzepatide use in patients at increased risk of cardiovascular events: a systematic review with meta-analysis and Trial Sequential Analysis
Sillassen, C. D. B., Faltermeier, P., Bjerg, J. L., Andersen, R. K., Petersen, J. J., Andersen, P. B., Kamp, C. B., Karlsson, F., Grand, J., Dominguez, H., Frølich, A., Gæde, P., Gluud, C., Mathiesen, O. & Jakobsen, J. C., 27 Mar 2026, In: BMC Medicine. 24, 1Research output: Contribution to journal › Review › Research › peer-review
Open Access -
Two phenotypes of metabolic cardiomyopathy: Data-driven cluster analysis of non-invasively determined cardiovascular phenotypical traits
Madsen, P. L., Mizrak, I., Sørensen, M. H., Gæde, P. H. & Bojer, A. S., Feb 2026, In: Diabetes Research and Clinical Practice. 232, 113081.Research output: Contribution to journal › Article › Research › peer-review
Open Access
Press/Media
-
Wegovy og Ozempic kan gavne patienter med skizofreni
Uhrenholt, N. G., Arnfred, S. M., Gæde, P. H. & Düring, S. W.
20/09/25
1 item of Media coverage
Press/Media